資源描述：
《加味小建中湯治療慢性淺表性胃炎的臨床療效觀察》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。
1、加味小建中湯治療慢性淺表性胃炎的臨床療效觀察【摘要】目的探討加味小建中湯治療慢性淺表性胃炎的臨床療效。方法92例慢性淺表性胃炎患者作為研究對(duì)象，隨機(jī)分為對(duì)照組和觀察組，每組46例。對(duì)照組患者口服雷貝拉唑膠囊進(jìn)行治令令，觀察組患者采用加味小建中湯治療。觀察比較兩組的臨床治療效果以及不良反應(yīng)發(fā)生情況。結(jié)果經(jīng)過(guò)治療后，對(duì)照組患者的臨床總有效率為67.39%，低于觀察組的93.48%,差異具有統(tǒng)計(jì)學(xué)意義。對(duì)照組患者的不良反應(yīng)發(fā)生率為21.74%，高于觀察組的6.52%，差異具有統(tǒng)計(jì)學(xué)意義。結(jié)論加味小建中湯能有效治療慢性淺表性胃炎，具有較好的臨床療效，并且不良反應(yīng)發(fā)生
2、率較低，值得臨床推廣使用?！娟P(guān)鍵詞】加味小建中湯；慢性淺表性胃炎；臨床療效DOI：10.14163/j.cnki.ll-5547/r.2017.16.013ObservationonclinicalcurativeeffectofmodifiedXiaojianzhongdecoctioninthetreatmentofchronicsuperficialgastritisLIANGQi-min.DepartmentofTraditionalChineseMedicine，GuangdongMedicalUniversityChashanHospital，加
3、味小建中湯治療慢性淺表性胃炎的臨床療效觀察【摘要】目的探討加味小建中湯治療慢性淺表性胃炎的臨床療效。方法92例慢性淺表性胃炎患者作為研究對(duì)象，隨機(jī)分為對(duì)照組和觀察組，每組46例。對(duì)照組患者口服雷貝拉唑膠囊進(jìn)行治令令，觀察組患者采用加味小建中湯治療。觀察比較兩組的臨床治療效果以及不良反應(yīng)發(fā)生情況。結(jié)果經(jīng)過(guò)治療后，對(duì)照組患者的臨床總有效率為67.39%，低于觀察組的93.48%,差異具有統(tǒng)計(jì)學(xué)意義。對(duì)照組患者的不良反應(yīng)發(fā)生率為21.74%，高于觀察組的6.52%，差異具有統(tǒng)計(jì)學(xué)意義。結(jié)論加味小建中湯能有效治療慢性淺表性胃炎，具有較好的臨床療效，并且不良反應(yīng)發(fā)生率
4、較低，值得臨床推廣使用?！娟P(guān)鍵詞】加味小建中湯；慢性淺表性胃炎；臨床療效DOI：10.14163/j.cnki.ll-5547/r.2017.16.013ObservationonclinicalcurativeeffectofmodifiedXiaojianzhongdecoctioninthetreatmentofchronicsuperficialgastritisLIANGQi-min.DepartmentofTraditionalChineseMedicine，GuangdongMedicalUniversityChashanHospital，Do
5、ngguan523380，China【Abstract】ObjectiveToexploretheclinicalcurativeeffectofmodifiedXiaojianzhongdecoctioninthetreatmentofchronicsuperficialgastritis.MethodsAtotalof92chronicsuperficialgastritispatientsasstudysubjectswererandomlydividedintocontrolgroupandobservationgroup，with46casesin
6、eachgroup.Thecontrolgroupreceivedoralrabeprazolecapsulefortreatment，andtheobservationgroupreceivedmodifiedXiaojianzhongdecoctionfortreatment.Observationandcomparisonweremadeonclinicaltherapeuticeffectandadversereactionsoccurrencesituationintwogroups.ResultsAftertreatment，thecontrol
7、grouphadlowerclinicaltotaleffectiverateas67.39%than93.48%intheobservationgroup,andthedifferencehadstatisticalsignificance.Thecontrolgrouphadhigherincidenceofadversereactionsas21.74%than6.52%inthecontrolgroup，andthedifferencehadstatisticalsignificance.ConclusionModifiedXiaojianzhong
8、decoctionshowsgoodclinical
